0000899243-16-024693.txt : 20160706 0000899243-16-024693.hdr.sgml : 20160706 20160706214905 ACCESSION NUMBER: 0000899243-16-024693 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160705 FILED AS OF DATE: 20160706 DATE AS OF CHANGE: 20160706 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XENOPORT INC CENTRAL INDEX KEY: 0001130591 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943330837 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 SEAPORT BLVD., SUITE 300 CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 4086167200 MAIL ADDRESS: STREET 1: 2000 SEAPORT BLVD., SUITE 300 CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BATES GREGORY T CENTRAL INDEX KEY: 0001551245 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51329 FILM NUMBER: 161755451 MAIL ADDRESS: STREET 1: 3410 CENTRAL EXPRESSWAY CITY: SANTA CLARA STATE: CA ZIP: 95051 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-07-05 1 0001130591 XENOPORT INC XNPT 0001551245 BATES GREGORY T C/O XENOPORT, INC. 2000 SEAPORT BOULEVARD, SUITE 300 REDWOOD CITY CA 94063 0 1 0 0 See Remarks Common Stock 2016-07-05 4 U 0 45097 7.03 D 0 D Stock Options 4.34 2016-07-05 4 D 0 5834 7.03 D 2022-01-13 Common Stock 5834 0 D Stock Options 5.38 2016-07-05 4 D 0 20000 7.03 D 2022-06-01 Common Stock 20000 0 D Stock Options 6.38 2016-07-05 4 D 0 47000 7.03 D 2024-02-24 Common Stock 47000 0 D Stock Options 6.38 2016-07-05 4 D 0 24000 7.03 D 2024-02-24 Common Stock 24000 0 D Stock Options 4.90 2016-07-05 4 D 0 40000 7.03 D 2026-01-26 Common Stock 40000 0 D Restricted Stock Units 2016-07-05 4 D 0 5000 7.03 D Common Stock 5000 0 D Restricted Stock Units 2016-07-05 4 D 0 7000 7.03 D Common Stock 7000 0 D Restricted Stock Units 2016-07-05 4 D 0 5625 7.03 D Common Stock 5625 0 D Restricted Stock Units 2016-07-05 4 D 0 15000 7.03 D Common Stock 15000 0 D Restricted Stock Units 2016-07-05 4 D 0 15000 7.03 D Common Stock 15000 0 D Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated May 21, 2016, by and among XenoPort, Inc. ("XenoPort"), Arbor Pharmaceuticals, LLC ("Arbor") and AP Acquisition Sub, Inc. ("AP Acquisition Sub"), a wholly owned subsidiary of Arbor, immediately prior to the Acceptance Time (as defined in the Merger Agreement), each outstanding and unexercised option to purchase shares of common stock of XenoPort was fully vested, cancelled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash equal to: (A) $7.03 per share minus (B) the exercise price per share of common stock of XenoPort. Each restricted stock unit ("RSU") represents the right to receive one share of common stock of XenoPort. Pursuant to the terms of the Merger Agreement, immediately prior to the Acceptance Time (as defined in the Merger Agreement), each outstanding RSU was fully vested, cancelled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash equal to $7.03 per share. SENIOR VP OF REGULATORY AFFAIRS AND QUALITY /s/ William G. Harris, as Attorney-in-Fact 2016-07-06